Evaluating the prognostic and predictive potential of FKBPL and associated proteins as biomarkers in breast and ovarian cancer
Despite adjuvant systemic therapies improving breast cancer survival rates, some patients are over- or under-treated. This is particularly problematic for the management of early stage ER+/LN- breast cancers. Identifying patients at a higher risk of relapse for whom additional adjuvant chemotherapy...
| Main Author: | |
|---|---|
| Published: |
Queen's University Belfast
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.677957 |